62 related articles for article (PubMed ID: 6539216)
1. Low-dosed antithyroid drug monotherapy in hyperthyroidism.
Seidel C; Ziegelitz D; Frenzel R; Dittmer T
Exp Clin Endocrinol; 1984 Mar; 83(1):73-86. PubMed ID: 6539216
[TBL] [Abstract][Full Text] [Related]
2. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
3. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function in breast-fed infants whose mothers take high doses of methimazole.
Azizi F; Hedayati M
J Endocrinol Invest; 2002 Jun; 25(6):493-6. PubMed ID: 12109618
[TBL] [Abstract][Full Text] [Related]
5. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
6. Long-term continuous methimazole or radioiodine treatment for hyperthyroidism.
Azizi F; Yousefi V; Bahrainian A; Sheikholeslami F; Tohidi M; Mehrabi Y
Arch Iran Med; 2012 Aug; 15(8):477-84. PubMed ID: 22827783
[TBL] [Abstract][Full Text] [Related]
7. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine.
Azizi F; Ataie L; Hedayati M; Mehrabi Y; Sheikholeslami F
Eur J Endocrinol; 2005 May; 152(5):695-701. PubMed ID: 15879354
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
10. Studies on doses of methimazole (MMI) and its administration regimen on broiler metabolism.
Rosebrough RW; Russell BA; McMurtry JP
Comp Biochem Physiol A Mol Integr Physiol; 2006 Jan; 143(1):35-41. PubMed ID: 16337159
[TBL] [Abstract][Full Text] [Related]
11. [Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients].
Meyer-Gessner M; Benker G; Olbricht T; Windeck R; Cissewski K; Reiners C; Reinwein D
Dtsch Med Wochenschr; 1989 Feb; 114(5):166-71. PubMed ID: 2464468
[TBL] [Abstract][Full Text] [Related]
12. Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects.
Kasraee B; Safaee Ardekani GH; Parhizgar A; Handjani F; Omrani GR; Samani M; Nikbakhsh M; Tanideh N; Eshraghian A; Sorg O; Saurat JH
Skin Pharmacol Physiol; 2008; 21(6):300-5. PubMed ID: 18667842
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
14. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
15. Children with hyperthyroidism younger than age 7 require higher mg/kg doses of methimazole to normalize free T4 compared to older children.
Stafford D; Vaidyanathan P; Kaplowitz P
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1339-42. PubMed ID: 26226121
[TBL] [Abstract][Full Text] [Related]
16. Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study.
Faber J; Perrild H; Johansen JS
Horm Metab Res; 1991 Mar; 23(3):135-8. PubMed ID: 1864560
[TBL] [Abstract][Full Text] [Related]
17. [Prospective study on the relationship between treatment duration of antithyroid drug and remission rate of Graves' disease].
Liu C; Duan Y; Wu X
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):835-7. PubMed ID: 11218878
[TBL] [Abstract][Full Text] [Related]
18. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
19. Laboratory tests for evaluating thyroid therapy.
Kabadi UM
Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
[TBL] [Abstract][Full Text] [Related]
20. Single daily dose methimazole treatment of hyperthyroidism.
Bouma DJ; Kammer H
West J Med; 1980 Jan; 132(1):13-5. PubMed ID: 7376643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
